Research and innovation news

An innovative bedside genetic test developed by MFT researchers could dramatically improve outcomes for thousands of people in the UK affected by stroke each year.

Women treated for ovarian cancer caused by an inherited faulty gene have a lower risk of developing breast cancer following that treatment, new research from MFT has revealed.

Researchers are to trial a ground-breaking screening test for pre-eclampsia, a potentially life-threatening condition affecting pregnant women and their unborn babies.

Innovative research is investigating if a portable device could significantly improve life for the more than 36,500 people in the UK every year left with permanent arm weakness after a stroke.

Manchester University NHS Foundation Trust (MFT) has now started a recommendations review on the benefits, limitations and implications of transcutaneous bilirubin (TCB) monitoring devices.

The new NIHR HealthTech Research Centre in Emergency and Acute Care marked its official opening with a launch event in Manchester.

The Academy of Medical Science has elected Professor Bill Newman, Consultant in Genomic Medicine, Manchester Centre for Genomic Medicine, Saint Mary’s Hospital, to its prestigious Fellowship.

Bruntwood SciTech has celebrated the topping out of its latest innovative lab and workspace offering, Citylabs 4.0 located within Manchester University NHS Foundation Trust’s (MFT) Oxford Road Campus.